The Office of Therapeutics Alliances actively seeks partnerships with established biopharma companies, startups, entrepreneurs, investors, nonprofits and foundations focused on specific disease areas and therapeutics development. Moreover, OTA has developed mechanisms for flexible structuring of collaborations and licensing at different stages of its portfolio activities. Potential partners can engage us on pipeline projects being advanced by OTA to determine progress in reaching key inflection points. Alternatively, potential partners can be involved at the onset by co-funding with OTA a project work plan in return for future rights, such as a right of first negotiation.
OTA encourages potential partners to peruse our portfolio [1] as well as the technologies listed by the NYU Office of Industrial Liaison [2]. We look forward to discussing how we can collaborate to maximize the therapeutic potential of biomedical breakthroughs discovered here at NYU.